# A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013)

> **NCT01737684** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 16 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Vibegron

## Key facts

- **NCT ID:** NCT01737684
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-15
- **Primary completion:** 2013-06-14
- **Final completion:** 2013-06-14
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737684, "A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01737684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*